India Delays Enforcement of BIS Rules on 3 Chemicals Until March 2026
Exporters to India just gained a critical extension. On April 10, India’s Department of Chemicals and Petrochemicals confirmed that mandatory quality orders for three key industrial chemicals — Vinyl Acetate Monomer, Methyl Acrylate, and Ethyl Acrylate — have been postponed by a full year. These regulations, which were initially scheduled to begin on March 31, 2025, will now take effect on March 31, 2026.
Once enforced, the quality control orders will require all products to meet Indian Standards and obtain BIS certification before entering the Indian market. Any product without the BIS standard mark will be denied entry.
Exporters are urged to act early. The 12-month delay offers a valuable window to complete product testing, certification, and regulatory alignment. Missing the revised deadline could mean a complete market shutdown for non-compliant shipments.
2026-09-12
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
German Chemical Industry Output Slumps to Lowest Utilization Rate Since 1991
-
The Shipping Cold War Sets Sail: The Triple Game Behind China’s Sanctions on Hanwha Ocean
-
China’s Titanium Dioxide Giant Makes a Move: LB Group Acquires UK Venator Assets
-
Aramco Acquires Sumitomo’s Stake for $702 Million, Boosting Control of Petro Rabigh to 60% — What Global Ambitions Does This Move Reveal?
-
Do You Know the Food Zero Additives?
-
Wanhua Chemical’s 2025 Revenue Exceeds RMB 200 Billion While Net Profit Remains Under Pressure
-
Fertilizer Costs Rise as Middle East Tensions Pressure Global Food Production
-
Fertilizer Costs Rise as Middle East Tensions Pressure Global Food Production
-
Platinum Chemotherapy Shortages Expose the Fragility of Essential API Supply
-
Solvay’s Zhenjiang Plant Expansion Goes Online, Doubling Electronic-Grade Hydrogen Peroxide Output to Support Semiconductor Advancements
Recommend Reading
-
Vertex Pushes Gene Therapy Into Younger Children With Blood Disorders
-
China's National Narcotics Control Commission Issues Important Notice: Beware of These 8 Chemicals Being Diverted for Drug Production
-
Lilly’s Mounjaro Enters China’s State Insurance System
-
A New Obesity Pill Enters the Arena With Double-Digit Weight Loss
-
Wegovy Slips on Price While Mounjaro Defends Its Weight-Loss Crown
-
Insufficient Demand for Cyclohexane in China, Weak Market Situation Persists
-
Coke market prices show strong performance in China
-
Business Society’s DOP Market Outlook on August 24, 2026: Short-Term Correction
-
Business Society’s Market Outlook for Formic Acid on August 24, 2026: Volatile
-
Cost-side support weakens, PTA price center of gravity continues to shift downward